Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America

ABSTRACT: Antibodies are an essential component of the adaptative immune response and hold long-term memory of the immunological experiences throughout life. Antibody defects represent approximately half of the well-known primary immunodeficiencies requiring immunoglobulin replacement therapy. In th...

Full description

Autores:
Condino Neto, Antonio
Costa Carvalho, B. T.
Grumach, A. S.
King, A.
Bezrodnik, L.
Oleastro, M.
Leiva, L.
Porras, O.
Espinosa Rosales, F. J.
Franco Restrepo, José Luis
Sorensen, R. U.
Tipo de recurso:
Article of investigation
Fecha de publicación:
2014
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/21292
Acceso en línea:
http://hdl.handle.net/10495/21292
Palabra clave:
Inmunoglobulinas
Immunoglobulins
Enfermedades de Inmunodeficiencia Primaria
Primary Immunodeficiency Diseases
América Latina
Latin America
Immunoglobulin replacement therapy
Subcutaneous immunoglobulin
Rights
openAccess
License
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
id UDEA2_8070b56ce3225a94dd843612a334ff70
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/21292
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America
title Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America
spellingShingle Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America
Inmunoglobulinas
Immunoglobulins
Enfermedades de Inmunodeficiencia Primaria
Primary Immunodeficiency Diseases
América Latina
Latin America
Immunoglobulin replacement therapy
Subcutaneous immunoglobulin
title_short Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America
title_full Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America
title_fullStr Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America
title_full_unstemmed Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America
title_sort Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America
dc.creator.fl_str_mv Condino Neto, Antonio
Costa Carvalho, B. T.
Grumach, A. S.
King, A.
Bezrodnik, L.
Oleastro, M.
Leiva, L.
Porras, O.
Espinosa Rosales, F. J.
Franco Restrepo, José Luis
Sorensen, R. U.
dc.contributor.author.none.fl_str_mv Condino Neto, Antonio
Costa Carvalho, B. T.
Grumach, A. S.
King, A.
Bezrodnik, L.
Oleastro, M.
Leiva, L.
Porras, O.
Espinosa Rosales, F. J.
Franco Restrepo, José Luis
Sorensen, R. U.
dc.subject.decs.none.fl_str_mv Inmunoglobulinas
Immunoglobulins
Enfermedades de Inmunodeficiencia Primaria
Primary Immunodeficiency Diseases
América Latina
Latin America
topic Inmunoglobulinas
Immunoglobulins
Enfermedades de Inmunodeficiencia Primaria
Primary Immunodeficiency Diseases
América Latina
Latin America
Immunoglobulin replacement therapy
Subcutaneous immunoglobulin
dc.subject.proposal.spa.fl_str_mv Immunoglobulin replacement therapy
Subcutaneous immunoglobulin
description ABSTRACT: Antibodies are an essential component of the adaptative immune response and hold long-term memory of the immunological experiences throughout life. Antibody defects represent approximately half of the well-known primary immunodeficiencies requiring immunoglobulin replacement therapy. In this article, the authors review the current indications and therapeutic protocols in the Latin American environment. Immunoglobulin replacement therapy has been a safe procedure that induces dramatic positive changes in the clinical outcome of patients who carry antibody defects.
publishDate 2014
dc.date.issued.none.fl_str_mv 2014
dc.date.accessioned.none.fl_str_mv 2021-07-29T19:46:21Z
dc.date.available.none.fl_str_mv 2021-07-29T19:46:21Z
dc.type.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.hasversion.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.local.spa.fl_str_mv Artículo de investigación
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.issn.none.fl_str_mv 0301-0546
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/10495/21292
dc.identifier.doi.none.fl_str_mv 10.1016/j.aller.2012.09.006
dc.identifier.eissn.none.fl_str_mv 1578-1267
identifier_str_mv 0301-0546
10.1016/j.aller.2012.09.006
1578-1267
url http://hdl.handle.net/10495/21292
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv Allergol. immunopatol.
dc.rights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rights.accessrights.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.creativecommons.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.format.extent.spa.fl_str_mv 16
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Sociedad Española de Inmunología Clínica y Alergología Pediátrica
Elsevier
dc.publisher.group.spa.fl_str_mv Inmunodeficiencias Primarias
dc.publisher.place.spa.fl_str_mv Murcia, España
institution Universidad de Antioquia
bitstream.url.fl_str_mv http://bibliotecadigital.udea.edu.co/bitstream/10495/21292/1/CondinoAntonio_2012_GuidelinesHumanImmunoglobulin.pdf
http://bibliotecadigital.udea.edu.co/bitstream/10495/21292/2/license_rdf
http://bibliotecadigital.udea.edu.co/bitstream/10495/21292/3/license.txt
bitstream.checksum.fl_str_mv 277ca5557c95acc04bd2e317b12a133b
b88b088d9957e670ce3b3fbe2eedbc13
8a4605be74aa9ea9d79846c1fba20a33
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad de Antioquia
repository.mail.fl_str_mv andres.perez@udea.edu.co
_version_ 1805390213098242048
spelling Condino Neto, AntonioCosta Carvalho, B. T.Grumach, A. S.King, A.Bezrodnik, L.Oleastro, M.Leiva, L.Porras, O.Espinosa Rosales, F. J.Franco Restrepo, José LuisSorensen, R. U.2021-07-29T19:46:21Z2021-07-29T19:46:21Z20140301-0546http://hdl.handle.net/10495/2129210.1016/j.aller.2012.09.0061578-1267ABSTRACT: Antibodies are an essential component of the adaptative immune response and hold long-term memory of the immunological experiences throughout life. Antibody defects represent approximately half of the well-known primary immunodeficiencies requiring immunoglobulin replacement therapy. In this article, the authors review the current indications and therapeutic protocols in the Latin American environment. Immunoglobulin replacement therapy has been a safe procedure that induces dramatic positive changes in the clinical outcome of patients who carry antibody defects.COL001242616application/pdfengSociedad Española de Inmunología Clínica y Alergología PediátricaElsevierInmunodeficiencias PrimariasMurcia, Españainfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARTArtículo de investigaciónhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-nd/2.5/co/http://purl.org/coar/access_right/c_abf2https://creativecommons.org/licenses/by-nc-nd/4.0/Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin AmericaInmunoglobulinasImmunoglobulinsEnfermedades de Inmunodeficiencia PrimariaPrimary Immunodeficiency DiseasesAmérica LatinaLatin AmericaImmunoglobulin replacement therapySubcutaneous immunoglobulinAllergol. immunopatol.Allergologia et Immunopathologia245260423ORIGINALCondinoAntonio_2012_GuidelinesHumanImmunoglobulin.pdfCondinoAntonio_2012_GuidelinesHumanImmunoglobulin.pdfArtículo de investigaciónapplication/pdf1276782http://bibliotecadigital.udea.edu.co/bitstream/10495/21292/1/CondinoAntonio_2012_GuidelinesHumanImmunoglobulin.pdf277ca5557c95acc04bd2e317b12a133bMD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8823http://bibliotecadigital.udea.edu.co/bitstream/10495/21292/2/license_rdfb88b088d9957e670ce3b3fbe2eedbc13MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81748http://bibliotecadigital.udea.edu.co/bitstream/10495/21292/3/license.txt8a4605be74aa9ea9d79846c1fba20a33MD5310495/21292oai:bibliotecadigital.udea.edu.co:10495/212922021-07-29 14:46:21.666Repositorio Institucional Universidad de Antioquiaandres.perez@udea.edu.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